Meiqing Lou

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 3

Top Topics

Cognitive Impairment

Subarachnoid Hemorrhage

Lipopolysaccharide Induced

Top Venues

Cancer immunology, immunotherapy : CII

Oxidative medicine and cellular longevity

Cancer cell international

This page only lists publications with an associated author ORCID identifier.

Publications

Chaoyou Fang, Houshi Xu, Ling Yuan, Zhengyang Zhu, Xiaoyu Wang, Yibo Liu, Anke Zhang, Anwen Shao, Meiqing Lou
Natural Compounds for SIRT1-Mediated Oxidative Stress and Neuroinflammation in Stroke: A Potential Therapeutic Target in the Future. Oxidative medicine and cellular longevity 2022 (2022)
Houshi Xu, Anke Zhang, Xiaying Han, Yanning Li, Zeyu Zhang, Liying Song, Wei Wang, Meiqing Lou
ITGB2 as a prognostic indicator and a predictive marker for immunotherapy in gliomas. Cancer immunology, immunotherapy : CII (2021)
Houshi Xu, Qingwei Zhu, Lan Tang, Junkun Jiang, Huiwen Yuan, Anke Zhang, Meiqing Lou
Prognostic and predictive value of FCER1G in glioma outcomes and response to immunotherapy. Cancer cell international 21 (1) (2021)